Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportEducational Exhibits - Oncology

Heptathlon of Sustainable Meaningful Access to RadioPharmaceutical Therapy (RPT 3.0)

Babak Saboury, Faraz Farhadi, Julia Brosch-Lenz, Michael Morris, Eren Veziroglu, Aaron Pogue, Arman Rahmim, Munir Ghesani and Eliot Siegel
Journal of Nuclear Medicine June 2024, 65 (supplement 2) 241904;
Babak Saboury
1Institute of Nuclear Medicine, Bethesda, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Faraz Farhadi
2National Institutes of Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia Brosch-Lenz
3Institute of Nuclear Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Morris
4Institute of Nuclear Medicine, Bethesda, MD, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eren Veziroglu
3Institute of Nuclear Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aaron Pogue
5Institute of Nuclear Medicine (INM)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arman Rahmim
6University of British Columbia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Munir Ghesani
7Mount Sinai Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eliot Siegel
8Department of Radiology and Nuclear Medicine, University of Maryland Medical Center, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 65 no. supplement 2 241904

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online June 9, 2024.

Copyright & Usage 
© 2024

Author Information

  1. Babak Saboury1,
  2. Faraz Farhadi2,
  3. Julia Brosch-Lenz3,
  4. Michael Morris4,
  5. Eren Veziroglu3,
  6. Aaron Pogue5,
  7. Arman Rahmim6,
  8. Munir Ghesani7 and
  9. Eliot Siegel8
  1. 1Institute of Nuclear Medicine, Bethesda, MD
  2. 2National Institutes of Health
  3. 3Institute of Nuclear Medicine
  4. 4Institute of Nuclear Medicine, Bethesda, MD, US
  5. 5Institute of Nuclear Medicine (INM)
  6. 6University of British Columbia
  7. 7Mount Sinai Hospital
  8. 8Department of Radiology and Nuclear Medicine, University of Maryland Medical Center, USA

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: June 2024 to April 2025

AbstractFullPdf
Jun 20247400
Jul 202417000
Aug 202412200
Sep 20243300
Oct 20243600
Nov 202411100
Dec 20245200
Jan 20254100
Feb 20252700
Mar 20252800
Apr 20253600
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 65, Issue supplement 2
June 1, 2024
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Heptathlon of Sustainable Meaningful Access to RadioPharmaceutical Therapy (RPT 3.0)
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Heptathlon of Sustainable Meaningful Access to RadioPharmaceutical Therapy (RPT 3.0)
Babak Saboury, Faraz Farhadi, Julia Brosch-Lenz, Michael Morris, Eren Veziroglu, Aaron Pogue, Arman Rahmim, Munir Ghesani, Eliot Siegel
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241904;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Heptathlon of Sustainable Meaningful Access to RadioPharmaceutical Therapy (RPT 3.0)
Babak Saboury, Faraz Farhadi, Julia Brosch-Lenz, Michael Morris, Eren Veziroglu, Aaron Pogue, Arman Rahmim, Munir Ghesani, Eliot Siegel
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241904;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Advances in Therapeutic Managements in Lymphoma and the Role of FDG-PET/CT in Therapeutic Decision-Making
  • 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors: Review of Treatment Workflow and Challenging Clinical Scenarios
  • Imaging biomarkers for response assessment in Neuroendocrine tumors and role of dual tracer imaging
Show more Educational Exhibits - Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire